245 related articles for article (PubMed ID: 17379267)
1. Research approaches to address uncertainties in the risk assessment of arsenic in drinking water.
Hughes MF; Kenyon EM; Kitchin KT
Toxicol Appl Pharmacol; 2007 Aug; 222(3):399-404. PubMed ID: 17379267
[TBL] [Abstract][Full Text] [Related]
2. Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.
Kitchin KT; Conolly R
Chem Res Toxicol; 2010 Feb; 23(2):327-35. PubMed ID: 20035570
[TBL] [Abstract][Full Text] [Related]
3. Workshop overview: arsenic research and risk assessment.
Sams R; Wolf DC; Ramasamy S; Ohanian E; Chen J; Lowit A
Toxicol Appl Pharmacol; 2007 Aug; 222(3):245-51. PubMed ID: 17336359
[TBL] [Abstract][Full Text] [Related]
4. How can biologically-based modeling of arsenic kinetics and dynamics inform the risk assessment process? - A workshop review.
Kenyon EM; Klimecki WT; El-Masri H; Conolly RB; Clewell HJ; Beck BD
Toxicol Appl Pharmacol; 2008 Nov; 232(3):359-68. PubMed ID: 18687352
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous pregnancy loss in humans and exposure to arsenic in drinking water.
Bloom MS; Fitzgerald EF; Kim K; Neamtiu I; Gurzau ES
Int J Hyg Environ Health; 2010 Nov; 213(6):401-13. PubMed ID: 20889375
[TBL] [Abstract][Full Text] [Related]
6. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
Clewell HJ; Thomas RS; Gentry PR; Crump KS; Kenyon EM; El-Masri HA; Yager JW
Toxicol Appl Pharmacol; 2007 Aug; 222(3):388-98. PubMed ID: 17499324
[TBL] [Abstract][Full Text] [Related]
7. Unanswered questions in arsenic toxicology.
Gebel TW
J Environ Pathol Toxicol Oncol; 2001; 20(4):299-309. PubMed ID: 11797839
[TBL] [Abstract][Full Text] [Related]
8. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review.
Yoshida T; Yamauchi H; Fan Sun G
Toxicol Appl Pharmacol; 2004 Aug; 198(3):243-52. PubMed ID: 15276403
[TBL] [Abstract][Full Text] [Related]
9. A review and rationale for studying the cardiovascular effects of drinking water arsenic in women of reproductive age.
Kwok RK
Toxicol Appl Pharmacol; 2007 Aug; 222(3):344-50. PubMed ID: 17467762
[TBL] [Abstract][Full Text] [Related]
10. Risk assessment of arsenic-induced internal cancer at long-term low dose exposure.
Liao CM; Shen HH; Chen CL; Hsu LI; Lin TL; Chen SC; Chen CJ
J Hazard Mater; 2009 Jun; 165(1-3):652-63. PubMed ID: 19062162
[TBL] [Abstract][Full Text] [Related]
11. Arsenic and diabetes and hypertension in human populations: a review.
Chen CJ; Wang SL; Chiou JM; Tseng CH; Chiou HY; Hsueh YM; Chen SY; Wu MM; Lai MS
Toxicol Appl Pharmacol; 2007 Aug; 222(3):298-304. PubMed ID: 17307211
[TBL] [Abstract][Full Text] [Related]
12. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis.
Mink PJ; Alexander DD; Barraj LM; Kelsh MA; Tsuji JS
Regul Toxicol Pharmacol; 2008 Dec; 52(3):299-310. PubMed ID: 18783726
[TBL] [Abstract][Full Text] [Related]
13. Can we protect everybody from drinking water contaminants?
Howd RA
Int J Toxicol; 2002; 21(5):389-95. PubMed ID: 12396685
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease.
Lee MY; Bae ON; Chung SM; Kang KT; Lee JY; Chung JH
Toxicol Appl Pharmacol; 2002 Mar; 179(2):83-8. PubMed ID: 11884240
[TBL] [Abstract][Full Text] [Related]
15. Arsenic alters monocyte superoxide anion and nitric oxide production in environmentally exposed children.
Luna AL; Acosta-Saavedra LC; Lopez-Carrillo L; Conde P; Vera E; De Vizcaya-Ruiz A; Bastida M; Cebrian ME; Calderon-Aranda ES
Toxicol Appl Pharmacol; 2010 Jun; 245(2):244-51. PubMed ID: 20226805
[TBL] [Abstract][Full Text] [Related]
16. Research strategy for developing key information on bromate's mode of action.
Bull RJ; Cottruvo JA
Toxicology; 2006 Apr; 221(2-3):135-44. PubMed ID: 16298034
[TBL] [Abstract][Full Text] [Related]
17. Lead contamination in Uruguay: the "La Teja" neighborhood case.
Mañay N; Cousillas AZ; Alvarez C; Heller T
Rev Environ Contam Toxicol; 2008; 195():93-115. PubMed ID: 18418955
[TBL] [Abstract][Full Text] [Related]
18. A Weibull-PBPK model for assessing risk of arsenic-induced skin lesions in children.
Liao CM; Lin TL; Chen SC
Sci Total Environ; 2008 Mar; 392(2-3):203-17. PubMed ID: 18207220
[TBL] [Abstract][Full Text] [Related]
19. Association of glutathione S-transferase Ω 1-1 polymorphisms (A140D and E208K) with the expression of interleukin-8 (IL-8), transforming growth factor beta (TGF-β), and apoptotic protease-activating factor 1 (Apaf-1) in humans chronically exposed to arsenic in drinking water.
Escobar-García DM; Del Razo LM; Sanchez-Peña LC; Mandeville PB; Lopez-Campos C; Escudero-Lourdes C
Arch Toxicol; 2012 Jun; 86(6):857-68. PubMed ID: 22293942
[TBL] [Abstract][Full Text] [Related]
20. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects.
Schuhmacher-Wolz U; Dieter HH; Klein D; Schneider K
Crit Rev Toxicol; 2009; 39(4):271-98. PubMed ID: 19235533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
